Basic Information
ThinkCyte, Inc. was founded in 2016 and is led by CEO Waichiro Katsuda. It is a biotechnology company that leverages integrated multidisciplinary technologies to develop innovative life science research, diagnostics, and therapies. The company focuses on drug discovery, cell therapy, and diagnostic platforms using its proprietary image-based high-throughput cell sorting technology, Ghost Cytometry. In June 2019, the company was selected by Japan's Ministry of Economy, Trade and Industry as part of the J-Startup program.
ThinkCyte, Inc.
Tokyo,Tokyo,Japan
15~50 people
February 01, 2016
--